These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34603196)

  • 1. Serum Afamin a Novel Marker of Increased Hepatic Lipid Content.
    Kurdiova T; Balaz M; Kovanicova Z; Zemkova E; Kuzma M; Belan V; Payer J; Gasperikova D; Dieplinger H; Ukropcova B; Ukropec J
    Front Endocrinol (Lausanne); 2021; 12():670425. PubMed ID: 34603196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals.
    Kollerits B; Lamina C; Huth C; Marques-Vidal P; Kiechl S; Seppälä I; Cooper J; Hunt SC; Meisinger C; Herder C; Kedenko L; Willeit J; Thorand B; Dähnhardt D; Stöckl D; Willeit K; Roden M; Rathmann W; Paulweber B; Peters A; Kähönen M; Lehtimäki T; Raitakari OT; Humphries SE; Vollenweider P; Dieplinger H; Kronenberg F
    Diabetes Care; 2017 Oct; 40(10):1386-1393. PubMed ID: 28877915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome.
    Seeber B; Morandell E; Lunger F; Wildt L; Dieplinger H
    Reprod Biol Endocrinol; 2014 Sep; 12():88. PubMed ID: 25208973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans.
    Hwang YC; Woo Oh S; Park SW; Park CY
    Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Laboratory Index, Based on Fasting Blood Parameters, Accurately Reflects Insulin Sensitivity.
    Karczewska-Kupczewska M; Nikołajuk A; Stefanowicz M; Matulewicz N; Arnoriaga-Rodriguez M; Fernandez-Real JM; Strączkowski M
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5208-e5221. PubMed ID: 34228124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage.
    Giannini C; Feldstein AE; Santoro N; Kim G; Kursawe R; Pierpont B; Caprio S
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2993-3000. PubMed ID: 23626003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive performance of traditional and novel lipid combined anthropometric indices to identify prediabetes.
    Ramdas Nayak VK; Nayak KR; Vidyasagar S; P R
    Diabetes Metab Syndr; 2020; 14(5):1265-1272. PubMed ID: 32688243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
    Sargin M; Uygur-Bayramiçli O; Sargin H; Orbay E; Yayla A
    J Clin Gastroenterol; 2003; 37(5):399-402. PubMed ID: 14564188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study.
    Köninger A; Mathan A; Mach P; Frank M; Schmidt B; Schleussner E; Kimmig R; Gellhaus A; Dieplinger H
    Reprod Biol Endocrinol; 2018 Mar; 16(1):30. PubMed ID: 29587878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lipopolysaccharide-Binding Protein With Aging-Related Adiposity Change and Prediabetes Among African Ancestry Men.
    Tilves CM; Zmuda JM; Kuipers AL; Nestlerode CS; Evans RW; Bunker CH; Patrick AL; Miljkovic I
    Diabetes Care; 2016 Mar; 39(3):385-91. PubMed ID: 26721818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of whole-body [
    Diamanti K; Visvanathar R; Pereira MJ; Cavalli M; Pan G; Kumar C; Skrtic S; Risérus U; Eriksson JW; Kullberg J; Komorowski J; Wadelius C; Ahlström H
    Sci Rep; 2020 May; 10(1):8343. PubMed ID: 32433479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Fat Volume is a Better Predictor of Insulin Resistance than Abdominal Wall Fat Index in Patients with Prediabetes and Type 2 Diabetes Mellitus.
    Aggarwal M; Verma G; Wahid A; Mathew S; Roat A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Serum Adiponectin and Vitamin D in Prediabetes and Diabetes Mellitus.
    Banerjee A; Khemka VK; Roy D; Poddar J; Roy TKS; Karnam SA
    Can J Diabetes; 2017 Jun; 41(3):259-265. PubMed ID: 28236525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.
    Neeland IJ; Turer AT; Ayers CR; Powell-Wiley TM; Vega GL; Farzaneh-Far R; Grundy SM; Khera A; McGuire DK; de Lemos JA
    JAMA; 2012 Sep; 308(11):1150-9. PubMed ID: 22990274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposity index and insulin secretion and action in first-degree relatives of subjects with type 2 diabetes.
    Yang Y; Feng Y; Ma X; Chen K; Wu N; Wang D; Li P; Wang M; Li Q; Zhang J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):315-21. PubMed ID: 25351905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study.
    Goldberg RB; Tripputi MT; Boyko EJ; Budoff M; Chen ZZ; Clark JM; Dabelea DM; Edelstein SL; Gerszten RE; Horton E; Mather KJ; Perreault L; Temprosa M; Wallia A; Watson K; Irfan Z
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4746-e4765. PubMed ID: 33705543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.